logo
‘Very concerning': One in three Australian men admit to intimate partner violence, horror study finds

‘Very concerning': One in three Australian men admit to intimate partner violence, horror study finds

West Australian2 days ago

A major new study revealing intimate partner violence is on the rise despite efforts to counter it is 'very concerning', Tanya Plibersek has said.
One in three men have admitted to abusing an intimate partner either emotionally or physically, according to the latest Australian Institute of Family Studies findings.
It marks an increase from one in four about a decade ago.
Reacting to the AIFS report on Tuesday, the Social Services Minister said it was clear the trend was headed in the 'wrong direction'.
'It looks at a large cohort of men over a long period of time, and what the research shows is that over about a decade, between the first report and the second report, the number of men who have ever used violence has increased from one in four to one in three,' Ms Plibersek told the ABC.
'That equates to about 120,000 extra men every year in Australia using violence for the first time in intimate relationships.
'Obviously that's a trend that's going in the wrong direction.
The study found emotional abuse was the most common form of intimate partner violence.
Thirty-two per cent of men in 2022 reported that they had made an intimate partner feel 'frightened or anxious'.
Meanwhile, 9 per cent admitted to 'hitting, slapping, kicking or otherwise physically hurting' their partner when angry.
But Ms Plibersek stressed the report offered 'some really good insights into what makes it more or less likely that men will ever use violence in an intimate relationship'.
'It shows that men who have good mental health, who have good social connections and social supports, and who have a good relationship with a father or father figure when they're young, are all less likely to use violence in their relationships,' she said.
According to the report, men with high levels of social support 'all of the time' were 26 per cent less likely to say they had committed intimate partner violence.
It also said men with strong relationships, with an affectionate father figure as a child, were 48 per cent less likely to say they had committed intimate partner violence.
In contrast, men with depressive symptoms were 62 per cent more likely to abuse a partner when compared to others without these symptoms.
'I think a lot of people in recent years have reported social isolation and loneliness as bigger features in their lives,' Ms Plibersek said.
'It shows why it's important that we invest in mental health supports and we're doing that as a government — an extra billion dollars with Medicare walk-in mental health clinics, expanding the number of Headspace clinics, reinstating telehealth psychiatry, telehealth consultations.
'All of those supports make a difference. It shows why it's important that we are investing to help women as they leave violence with the billion dollars extra for the Leaving Violence (Program), the extra housing and extra billion dollars for that.'
The government-funded study has tracked more than 16,000 boys and men since 2013 and added an additional 10,000 men in 2024-25.
It is the first of its kind in Australia.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

One in three Australian men report using emotional or physical violence
One in three Australian men report using emotional or physical violence

7NEWS

time10 hours ago

  • 7NEWS

One in three Australian men report using emotional or physical violence

More than one in three Australian men admit to having used emotional or physical violence against their partners, according to a world-first study. The alarming results are an increase from one in four men 10 years ago, with federal Social Services Minister Tanya Plibersek calling it a 'trend ... going in the wrong direction'. 'That equates to about 120,000 extra men every year in Australia using violence for the first time in intimate relationships,' she said. The Australian Institute of Family Studies' Australian Longitudinal Study on Male Health — the largest study of its kind in the world — surveyed about 16,000 men aged 18 to 65 in 2013-2014 and again in 2023-2024, with a further 10,000 individuals added to the database in the second survey. It asked questions including whether participants had ever behaved in a manner that had made a partner feel frightened or anxious, or had ever hit, slapped, kicked or otherwise physically hurt a partner when angry. By the second study, 35 per cent of participants answered yes to one or both of those questions compared with 24 per cent in the first survey. About 9 per cent of those involved in the second survey admitted to physically abusing their partner. Plibersek said the study results were concerning. 'It looks at a large cohort of men over a long period of time and, what the research shows is that over about a decade, between the first report and the second report, the number of men who have ever used violence has increased from one in four to one in three,' Plibersek told the ABC. 'Obviously, that's a trend that's going in the wrong direction.' But she said the research did offer 'good insights', revealing men who had an affectionate father figure as a child were 48 per cent less likely to have committed intimate partner violence. And men with high levels of social support 'all the time' were 26 per cent less likely to say they had committed intimate partner violence. 'It shows that men who have good mental health, who have good social connections and social supports, and who have a good relationship with a father or father figure when they're young, are all less likely to use violence in their relationships,' Plibersek told the ABC. Conversely, mental health issues such as depression can increase the incidence of violence. Men who reported moderate or severe depressive symptoms in 2013-2014 were 62 per cent more likely to report committing violence by the second survey, while those with mild depressive symptoms were 32 per cent more likely. Those who had experienced suicidal thoughts, plans or attempts were 47 per cent more likely to have committed some form of violence against a partner. 'Extent of the problem' Australian Institute of Family Studies director Liz Neville said : 'This unique data set, following men over a 10-year period, confirms the extent of the problem. 'With an estimated 120,000 men starting to use intimate partner violence each year across Australia, we can see more clearly how delays in effective interventions can have devastating consequences. 'Each act of violence harms individuals, families, and communities. We hope these disturbing numbers provide the impetus for further action by governments at all levels, underpinned by evidence.' However the research indicates programs which support men to develop good quality relationships, social connections and to seek support could contribute to a reduction in partner violence.

Health Check: Whether stoic or simply too poor, Australians spurn GP visits
Health Check: Whether stoic or simply too poor, Australians spurn GP visits

News.com.au

time15 hours ago

  • News.com.au

Health Check: Whether stoic or simply too poor, Australians spurn GP visits

Doctor visits dipped in April, reversing a recovery trend Mayne Pharma threatens to go legal in takeover dispute … but peace erupts at Cann Group with settlement of legal spat We're either a healthy lot, rely on Dr Google or simply can't afford to visit a GP anymore. Take your pick as to why our doctor visitations are running below the historic trend. Medicare data for April shows a resumption of a decline in doctors' visits, thus reversing a recent recovery. Bell Potter says the 12-month rolling rate slipped back to 0.8% from 2.3% in March and now is below the long-term median 1.4% growth. In April last year, the rolling rate had dipped to -3%. The slippage was most apparent in Queensland, which shows what stoic souls they are up north. Or maybe they couldn't get to their clinics because they were hemmed in by floods. The rate of doctors' visits has a direct impact on diagnostic imaging volumes and thus is relevant for stocks such as Sonic Healthcare (ASX:SHL), Integral Diagnostics (ASX:IDX), Healius (ASX:HLS) and Australian Clinical Labs (ASX:ACL). (Healius sold its 69 medical centres to private equity firm BGH Capital for $500 million in November 2020.) Macquarie Equities says both pathology and imaging volumes grew 4% in April, year on year. But the DI providers look to be protected by more expensive procedures – 'higher fee modalities', as the firm puts it – with benefits paid rising 8% in April for pathology and 7% for imaging. On the bright side, face-to-face GP visits have held up relative to telehealth and the former is likely to result in diagnostic referrals. So it's a bit of a mixed picture. The re-elected Albo's pledge to extend bulk billing might also ramp up volumes. What will restrain the pain at Mayne? Mayne Pharma's (ASX:MYX) takeover is in the balance, with a 10-day consultation period expiring without suitor Cosette Pharmaceuticals pulling the plug. Cosette alleged that events had resulted in a 'material adverse change', thus triggering the consultation period. Mayne denies these events were material. The FDA has accused Mayne Pharma of downplaying the risks of its oral birth control pill, Nextstellis. Mayne Pharma now says the agency is satisfied the company has addressed the identified issues. Mayne is also in a tat-for-tat legal dispute with the Nasdaq-listed Therapeutics MD, relating to Mayne's purchase of assets from the latter in 2022. While Cosette is yet to walk, the terms of the scheme implementation deed (SID) enable the suitor to do so any time up to the second court hearing to approve the deal. The affair may end up in the courts in a different way, given Mayne 'intends to take all reasonable steps to enforce its rights under the SID.' This includes litigation, of course. Mayne shares this morning surged 5%, but they remain 32% below Cosette's $7.40 a share cash offer. So investors are saying the deal might have a pulse, but not at the original offer price. Cann Group pots legal settlement Medical cannabis play Cann Group (ASX:CAN) has settled a legal dispute with the NZ-listed Rua Biosciences, which had sued a Cann subsidiary over a manufacturing and supply agreement. As is the norm, the agreement is confidential but doesn't involve any money changing hands. Instead, the parties have agreed that Cann will supply 'certain medicinal cannabis products' to Rua under 'agreed market standard commercial terms.' As far as legal spats go, it sounds like a reasonable result. Across the Tasman, Rua shares were up more than 7% this morning Cann shares were about 3% off the pace, having lost 65% of their value year to date. The first Australian company to receive an Australian cannabis research and cultivation licence, Cann produces from its modern Mildura facility. But in the current oversupplied market, it's not easy being green. Radiopharm tackles HER-2 cancers Radiopharm Theranostics (ASX:RAD) has dosed the first patient in its phase I trial to treat advanced HER2-positive solid tumours. A human epidermal growth factor receptor, HER2 is expressed in a variety of tumours including some breast cancers. Dubbed Heat, the study road tests Radiopharm's lutetium isotope-based therapy. Taking place at multiple local centres, the study has the usual safety and tolerability remits. It also aims for the optimal dosage for a phase II trial, as well as early efficacy signals. 'Despite progressive improvements in the management of metastatic HER2-positive disease, the majority of patients experience disease progression on current standard of care and require further therapeutic options,' Radiopharm CEO Riccardo Canevari says. On Monday, the company said preclinical data from another program showed 'favorable biodistribution and ... maintained tumor uptake.' This one refers to its lutetium-based monoclonal antibody RV01, which targets solid tumours expressing the B7H3 protein. This one is via a joint venture with Houston's MD Anderson Cancer Center to develop at least four radiopharmaceutical products. The next step is FDA assent to run a first-in-human trial, which the company hopes to kick off in 2026.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store